Serotonin transporter gene polymorphic element 5-HTTLPR increases the risk of sporadic parkinson's disease in Italy

European Neurology

Volumn 62, Issue 2, 2009, Pages 120-123

  Albani, Diego ^a   Vittori, Angelica ^a   Batelli, Sara ^a   Polito, Letizia ^a   De Mauro, Stefania ^a   Galimberti, Daniela ^b   Scarpini, Elio ^b   Lovati, Carlo ^c   Mariani, Claudio ^c   Forloni, Gianluigi ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

5 HTTLPR; Genetics; Parkinson's disease; Rs25531; Serotonin transporter

Indexed keywords

SEROTONIN TRANSPORTER;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE INSERTION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HAPLOTYPES; HUMANS; ITALY; LOGISTIC MODELS; MALE; MIDDLE AGED; MUTATION; ODDS RATIO; PARKINSON DISEASE; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RISK FACTORS; SEQUENCE ANALYSIS, DNA; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 66749141811     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000222784     Document Type: Article

References (21)

1. Von Campenhausen S, Bornschein B, Wick R, Bötzel K, Sampaio C, Poewe W, Oertel W, Siebert U, Berger K, Dodel R: Prevalence and incidence of Parkinson's disease in Europe. Eur Neuropsychopharmacol 2005; 4: 473- 490.
2. Belin AC, Westerlund M: Parkinson's disease: a genetic perspective. FEBS J 2008; 275: 1377-1383.
3. Hardy J, Cai H, Cookson MR, Gwinn-Hardy K, Singleton A: Genetics of Parkinson's disease and parkinsonism. Ann Neurol 2006; 60: 389-398.
4. The Michael J. Fox Foundation and the Alzheimer Research Forum: A database for Parkinson's disease genetic association studies developed by Massachusetts General Hospital/Harvard Medical School (www.pdgene. org).
5. Bonifati V: LRRK2 low-penetrance mutations (Gly2019Ser) and risk alleles (Gly2385Arg)-link ing fa milia l and sporadic Parkinson's disease. Neurochem Res 2007; 32: 1700 -1708.
6. Ross OA, Wu YR, Lee MC, Funayama M, Chen ML, Soto AI, Mata IF, Lee-Chen GJ, Ch en CM, Ta n g M, Zha o Y, H at tor i N, Fa r rer MJ, Tan EK, Wu RM: Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease. Ann Neurol 2008; 6 4: 88-92 .
7. Kish SJ, Tong J, Hornykiewicz O, Rajput A, Chang LJ, Guttman M, Furukawa Y: Preferential loss of serotonin markers in caudate versus putamen in Park inson's disease. Brain 2008; 131:120-131.
8. Guttman M, Boileau I, Warsh J, Saint-Cyr JA, Ginovart N, McCluskey T, Houle S, Wilson A, Mundo E, Rusjan P, Meyer J, Kish SJ: Brain serotonin transporter binding in non-depressed patients with Parkinson's disease. Eur J Neurol 2007; 14 : 523 -528.
9. Zhang X, Andren PE, Greengard P, Svenningsson P: Evidence for a role of the 5-HT1B receptor and its adaptor protein, p11, in L-DOPA treatment of an animal model of parkinsonism. Proc Natl Acad Sci USA 2008; 105:2163-2168.
10. Kish SJ: Biochemistry of Parkinson's disease: is a brain serotonergic deficiency a characteristic of idiopathic Parkinson's disease? Adv Neurol 20 03; 91 : 39 - 49.
11. 2A receptor and transporter genes. Neurosci Lett 2007; 422: 228-231.
12. Murphy DL, Lerner A, Rudnick G, Lesch KP: Serotonin transporter: gene, genetic disorders, and pharmacogenetics. Mol Interv 2004;4: 109-123.
13. Maeda T, Nagata K, Yoshida Y, Kannari K: Serotonergic hyperinnervation into the dopaminergic denervated striatum compensates for dopamine conversion from exogenously administered L -DOPA. Brain Res 2005; 1046:230-233.
14. Kannari K, Shen H, Arai A, Tomiyama M, Baba M: Reupta ke of L-DOPA-derived extracellular dopamine in the striatum with dopaminergic denervation via serotonin transporters. Neurosci Lett 2006; 402: 62-65.
15. Nakamura M, Ueno S, Sano A, Tanabe H: The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants. Mol Psychiatry 2000; 5:32-38.
16. Kraft JB, Slager SL, McGrath PJ, Hamilton SP: Sequence analysis of the serotonin transporter and associations with antidepressant response. Biol Psychiatry 2005; 58:374-381.
17. Wendland JR, Martin BJ, Kruse MR, Lesch KP, Murphy DL: Simultaneous genotyping of four functional loci of human SLC6A4, with a reappraisa l of 5-HTTLPR and rs25531. Mol Psychiatry 2006; 11:224-226.
18. Dannlowski U, Ohrmann P, Bauer J, Kugel H, Baune BT, Hohoff C, Kersting A, Arolt V, Heindel W, Deckert J, Suslow T: Serotonergic genes modulate amygdala activity in major depression. Genes Brain Behav 2007; 6: 672- 676.
19. Hastings WK: Monte Carlo sampling methods using Markov chains and their applications. Biometrika 1970; 57:97-109.
20. Miller MP: R by C: a program that performs Fisher's exact test on any sized contingency table through the use of the Metropolis algorithm (www.marksgeneticsoftware.net).
21. Preacher KJ: Calculation for the chi-square test: an interactive calculation tool for chisquare tests of goodness of fit and independence [computer software] (www.quantpsy. org), 2001.